CHADS. 2. score of 2 or less, stopping warfarin without providing bridging anticoagulation is acceptable. ... This patient does not have an increased risk for a thromboembolic event, so bridging anticoagulation is not needed.
Anticoagulation with warfarin or a newer anticoagulant, such as dabigatran, is required to manage this patient's long-term risk of cardioembolic stroke. ... Anticoagulation with a novel oral anticoagulant (such as dabigatran, rivaroxaban, or apixaban)
2012. The patients were randomized to retrievable inferior vena cava filter implantation plus anticoagulation (n=200) or anticoagulation alone (n=199) and were followed for 6 months. ... Patients with a contraindication to anticoagulation therapy and
The guideline on optimal management of anticoagulation offers 25 recommendations and two good-practice statements. ... Conditional recommendations address the choice of nonheparin anticoagulant for treatment of acute HIT.
1. The pathway addresses bleeding complications in patients taking direct oral anticoagulants or vitamin K antagonists, and it supplements the 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation ... Anticoagulation
Hospitalists need to become familiar with each of these new anticoagulants,” said Dr. ... Of course, simply prescribing an anticoagulant when it's needed is not sufficient.
Results were published online Sept. 27 by JACC: Clinical Electrophysiology. A third of the patients were discharged on anticoagulation. ... Anticoagulation was associated with a significantly increased risk of bleeding in patients with acute pulmonary
A meta-analysis found that more than a third of patients taking an anticoagulant before an intracerebral hemorrhage (ICH) restarted anticoagulation after the ICH, and they had lower rates of thromboembolic ... All involved anticoagulation with oral
The phenomenon of bilateral adrenal hemorrhage in APLS occurs rarely, and is confounded by the fact that most of these patients are on systemic anticoagulation. ... Anticoagulation failure can occur with DOACs in APLS, and warfarin remains the
Patients with atrial fibrillation and a CHA. 2. DS. 2. -VASc score of 1 may have a stroke risk high enough to benefit from novel oral anticoagulants, but likely not warfarin, ... 2. DS. 2. -VASc score of 1 would fall between those cutoffs, suggesting